In an observational study, antihypertensive treatment was not associated with reduced mortality or rates of CVD in low-risk patients with mild hypertension.
In a cohort study, use of β-blockers in the first trimester was not associated with increased risk of congenital overall or cardiac malformations.
A retrospective study showed better SBP during antihypertensive therapy and lower risk of antihypertensive treatment failure in hypertensive patients with good oral health, as compared with those with periodontitis.
A community-based lifestyle intervention resulted in greater SBP reduction when compared with health education alone in hypertensive blacks, as observed in the FAITH randomized trial.
This is a summary of the presentation by Lars Rydén, in which he presents which patients will likely benefit from GLP-1RA therapy by discussing differences observed between GLP-1RA trials.
BP lowering with amlodipine and lipid lowering with atorvastatin still resulted in lower rates of stroke and CV death in hypertensive patients after more than a decade, as the results of a long-term follow-up of data from the ASCOT trial show.
In patients with a systolic BP between 120 and <140 mmHg, a diastolic BP between 70 and <80 mmHg was associated with a lower risk of adverse outcomes as compared to lower and higher DBP.
ESC 2018 In this debate, the different viewpoints supporting the European and American Guidelines on Hypertension were fiercely defended, although overlap prevails.
ESC 2018 Key messages of the 2018 ESC/ESH Guidelines for hypertension include no change in the definition of hypertension, treatment for those with high-normal BP and grade I hypertension and initiation of two-drug combination.
This is a summary of presentation given by prof. Grobbee, in which he discusses how to reduce CV risk in patients with T2DM, considering the effects of glucose control and the effect of newer agents.
Black individuals have a significantly higher risk for hypertension compared with whites, from young adulthood through middle age, irrespective of BP before the age of 30 years.
BP responses to exercise are similar in treated–controlled, treated-uncontrolled, and untreated hypertensives but higher compared with normotensives.